Published in J Virol on October 31, 2012
Structure of a dengue virus envelope protein late-stage fusion intermediate. J Virol (2012) 1.12
Atomic-level functional model of dengue virus Envelope protein infectivity. Proc Natl Acad Sci U S A (2013) 0.97
Relating structure to evolution in class II viral membrane fusion proteins. Curr Opin Virol (2014) 0.83
B cell response and mechanisms of antibody protection to West Nile virus. Viruses (2014) 0.78
Crystal Structure of Glycoprotein C from a Hantavirus in the Post-fusion Conformation. PLoS Pathog (2016) 0.78
The Ancient Gamete Fusogen HAP2 Is a Eukaryotic Class II Fusion Protein. Cell (2017) 0.77
Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability. Nat Commun (2017) 0.75
A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease. Antiviral Res (2016) 0.75
Structural Basis for CD4+ T Cell Epitope Dominance in Arbo-Flavivirus Envelope Proteins: A Meta-Analysis. Viral Immunol (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Clustal W and Clustal X version 2.0. Bioinformatics (2007) 126.47
PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr (2002) 53.61
Inference of macromolecular assemblies from crystalline state. J Mol Biol (2007) 44.95
Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A (2001) 42.14
Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc (2009) 32.64
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr D Biol Crystallogr (2004) 14.28
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res (2004) 11.53
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell (2002) 9.13
Viral membrane fusion. Nat Struct Mol Biol (2008) 8.54
Structure of the dengue virus envelope protein after membrane fusion. Nature (2004) 7.97
A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A (2003) 7.76
PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res (2007) 7.07
Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol (1989) 7.06
Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard. Acta Crystallogr D Biol Crystallogr (2009) 6.47
The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell (2001) 5.65
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med (2005) 5.09
Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J (2004) 4.05
Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature (2004) 4.02
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol (1995) 3.67
Conformational changes of the flavivirus E glycoprotein. Structure (2004) 3.66
Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol (2001) 3.58
Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature (2005) 3.51
Structure of West Nile virus. Science (2003) 3.48
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology (1983) 3.24
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol (2006) 3.23
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature (2010) 2.90
Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog (2008) 2.88
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol (2004) 2.64
Crystal structure of the West Nile virus envelope glycoprotein. J Virol (2006) 2.61
Membrane fusion process of Semliki Forest virus. I: Low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells. J Cell Biol (1992) 2.51
Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol (1991) 2.34
Epidemiology of Encephalitis: With Special Reference to the 1933 Epidemic. Am J Public Health Nations Health (1933) 2.33
Role of cholesterol in fusion of Semliki Forest virus with membranes. J Virol (1984) 2.32
Cryo-electron microscopy reveals the functional organization of an enveloped virus, Semliki Forest virus. Mol Cell (2000) 2.28
Membrane fusion mutants of Semliki Forest virus. J Cell Biol (1984) 2.27
Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol (2006) 2.20
The flaviviruses (group B arboviruses): a cross-neutralization study. J Gen Virol (1974) 2.18
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe (2008) 2.16
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol (2010) 2.14
Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J Biol Chem (2003) 2.09
Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus. Structure (2006) 2.05
Class II virus membrane fusion proteins. Virology (2006) 1.99
Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J (1994) 1.99
Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. J Virol (2006) 1.91
Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J (2009) 1.85
Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J Virol (2002) 1.83
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J Virol (2005) 1.72
The Story of the Epidemic of Encephalitis in St. Louis. Am J Public Health Nations Health (1933) 1.68
Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathog (2010) 1.67
Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. J Virol (2009) 1.65
The structural immunology of antibody protection against West Nile virus. Immunol Rev (2008) 1.63
Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J Med Virol (1995) 1.58
Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J Immunol (1984) 1.58
Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J Virol (2010) 1.58
Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J Virol (2009) 1.52
LABORATORY TRANSMISSION OF ST. LOUIS ENCEPHALITIS VIRUS BY THREE GENERA OF MOSQUITOES. J Exp Med (1943) 1.46
A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog (2009) 1.41
The DynDom database of protein domain motions. Bioinformatics (2003) 1.27
Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo. J Virol (2008) 1.26
Crystal structure of the Japanese encephalitis virus envelope protein. J Virol (2011) 1.26
Class I and class II viral fusion protein structures reveal similar principles in membrane fusion. Mol Membr Biol (2005) 1.18
Production of selenomethionine-labeled proteins in two-liter plastic bottles for structure determination. J Struct Funct Genomics (2004) 1.15
Saint Louis encephalitis virus, Brazil. Emerg Infect Dis (2007) 1.14
Human outbreak of St. Louis encephalitis detected in Argentina, 2005. J Clin Virol (2008) 1.13
Experimental vertical transmission of Saint Louis encephalitis virus by Florida mosquitoes. Am J Trop Med Hyg (1986) 1.07
Mutation analysis of the fusion domain region of St. Louis encephalitis virus envelope protein. Virology (2006) 1.05
Comparison of argentinean saint louis encephalitis virus non-epidemic and epidemic strain infections in an avian model. PLoS Negl Trop Dis (2011) 0.92
Mutational analysis of the zippering reaction during flavivirus membrane fusion. J Virol (2011) 0.92
St. Louis encephalitis outbreak in Louisiana in 2001. J La State Med Soc (2003) 0.91
Epidemiological features of and public health response to a St. Louis encephalitis epidemic in Florida, 1990-1. Epidemiol Infect (2000) 0.83
Epidemiologic aspects of a St. Louis encephalitis outbreak in Fort Walton Beach, Florida in 1980. Am J Trop Med Hyg (1994) 0.79
Clinical Observations and Laboratory Investigations on the 1933 Epidemic of Encephalitis in St. Louis. Bull N Y Acad Med (1934) 0.78
Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A (2002) 5.17
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med (2005) 5.09
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Blood (2008) 3.89
Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature (2005) 3.51
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol (2008) 3.27
The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe (2007) 3.25
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol (2006) 3.23
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol (2007) 2.89
Crystal structure of the West Nile virus envelope glycoprotein. J Virol (2006) 2.61
Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol (2007) 2.30
Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol (2002) 2.26
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe (2008) 2.16
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J Virol (2010) 2.14
Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol (2003) 2.09
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog (2010) 2.03
West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci U S A (2006) 1.96
Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol (2006) 1.92
Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J Virol (2006) 1.91
Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol (2007) 1.89
Accessory protein recruitment motifs in clathrin-mediated endocytosis. Structure (2002) 1.89
Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J (2009) 1.85
West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody. Proc Natl Acad Sci U S A (2006) 1.83
MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci U S A (2009) 1.81
Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J Biol Chem (2005) 1.72
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med (2008) 1.67
The structural immunology of antibody protection against West Nile virus. Immunol Rev (2008) 1.63
Oncogenic potential of the DNA replication licensing protein CDT1. Oncogene (2002) 1.62
Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J Virol (2010) 1.58
Identification of somatic JAK1 mutations in patients with acute myeloid leukemia. Blood (2007) 1.55
N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. Nat Immunol (2004) 1.51
Structural mechanism of ER retrieval of MHC class I by cowpox. PLoS Biol (2012) 1.49
Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step. J Virol (2011) 1.49
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus. PLoS Pathog (2013) 1.47
Endogenous MHC-related protein 1 is transiently expressed on the plasma membrane in a conformation that activates mucosal-associated invariant T cells. J Immunol (2011) 1.47
Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus. J Virol (2012) 1.43
Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation. J Immunol (2005) 1.42
A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes. PLoS Pathog (2009) 1.41
Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell Host Microbe (2007) 1.37
Dual engagement regulation of protein interactions with the AP-2 adaptor alpha appendage. J Biol Chem (2004) 1.34
Patterns of nonclassical MHC antigen presentation. Nat Immunol (2007) 1.32
Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells. J Virol (2007) 1.32
Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope. PLoS Pathog (2012) 1.31
Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell (2002) 1.29
Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus. Cell Host Microbe (2009) 1.27
Biochemical features of the MHC-related protein 1 consistent with an immunological function. J Immunol (2003) 1.27
Structural definition of the F-actin-binding THATCH domain from HIP1R. Nat Struct Mol Biol (2006) 1.26
Crystal structure of the Japanese encephalitis virus envelope protein. J Virol (2011) 1.26
Capturing a flavivirus pre-fusion intermediate. PLoS Pathog (2009) 1.24
Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection. J Virol (2013) 1.22
Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein. Structure (2005) 1.16
Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release. J Biol Chem (2010) 1.13
Ligands for murine NKG2D display heterogeneous binding behavior. Eur J Immunol (2002) 1.12
The role of mhc polymorphism in anti-microbial resistance. Microbes Infect (2004) 1.07
Structural determinants of herpesvirus entry mediator recognition by murine B and T lymphocyte attenuator. J Immunol (2008) 1.06
RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor. Structure (2012) 1.04
A structural explanation for the antithrombotic activity of ARC1172, a DNA aptamer that binds von Willebrand factor domain A1. Structure (2009) 1.03
Disulfide bond engineering to trap peptides in the MHC class I binding groove. J Immunol (2007) 1.02
The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin. J Immunol (2007) 1.01
Structural definition of the H-2Kd peptide-binding motif. J Biol Chem (2006) 1.01
The unusual dynamics of parasite actin result from isodesmic polymerization. Nat Commun (2013) 1.01
T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope. J Virol (2009) 1.00
Structural engineering of pMHC reagents for T cell vaccines and diagnostics. Chem Biol (2007) 0.99
Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide. J Biol Chem (2003) 0.99
Subversion of cytokine networks by virally encoded decoy receptors. Immunol Rev (2012) 0.98
Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc Natl Acad Sci U S A (2014) 0.97
Structural determinants of chemokine binding by an Ectromelia virus-encoded decoy receptor. J Virol (2006) 0.96
A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition. J Virol (2010) 0.96
Recognition of open conformers of classical MHC by chaperones and monoclonal antibodies. Immunol Rev (2005) 0.95
Identification and sequencing of a novel rodent gammaherpesvirus that establishes acute and latent infection in laboratory mice. J Virol (2011) 0.95
Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming. Proc Natl Acad Sci U S A (2012) 0.93
Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature. Virology (2011) 0.92
Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor. J Exp Med (2007) 0.92
BTLA and HVEM cross talk regulates inhibition and costimulation. Adv Immunol (2006) 0.91
An unusual Fc receptor-related protein expressed in human centroblasts. Proc Natl Acad Sci U S A (2002) 0.90
Crystal structure of the cowpox virus-encoded NKG2D ligand OMCP. J Virol (2012) 0.89
Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin. J Immunol (2010) 0.89
Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides. J Biol Chem (2008) 0.87
The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states. J Virol (2013) 0.86
Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur J Immunol (2003) 0.86
Preparation of stable single-chain trimers engineered with peptide, beta2 microglobulin, and MHC heavy chain. Curr Protoc Immunol (2009) 0.84
Basic and translational applications of engineered MHC class I proteins. Trends Immunol (2010) 0.84
Structural basis for the restoration of TCR recognition of an MHC allelic variant by peptide secondary anchor substitution. J Exp Med (2004) 0.83
Cowpox virus employs a two-pronged strategy to outflank MHCI antigen presentation. Mol Immunol (2013) 0.82
Human C-type lectin domain family 4, member C (CLEC4C/BDCA-2/CD303) is a receptor for asialo-galactosyl-oligosaccharides. J Biol Chem (2011) 0.82
Structure, expression, and intracellular localization of the SARS-CoV accessory proteins 7a and 7b. Adv Exp Med Biol (2006) 0.81
Complex phenotypes in mosquitoes and mice associated with neutralization escape of a Dengue virus type 1 monoclonal antibody. Virology (2012) 0.81
MMTV superantigens coerce an unconventional topology between the TCR and MHC class II. J Immunol (2014) 0.79
The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1. Virology (2013) 0.78
Oxidative refolding from inclusion bodies. Methods Mol Biol (2014) 0.76
Ebola images emerge from the cave. Cell Host Microbe (2008) 0.75
Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor. J Virol (2013) 0.75
Target selection for structural genomics of infectious diseases. Methods Mol Biol (2014) 0.75